The Increased Frequency of Carbapenem Resistant Non Fermenting Gram Negative Pathogens as Causes of Health Care Associated Infections in Adult Cancer Patients

Hadir A. El-Mahallawy; Rasha M. Abdel Hamid; Safaa Shawky Hassan; Samah Radwan; Magdy Saber

doi:10.4236/jct.2015.610096

Home > Journals > Medicine & Healthcare > JCT

JCT> Vol.6 No.10, September 2015

Share This Article:

Open Access

The Increased Frequency of Carbapenem Resistant Non Fermenting Gram Negative Pathogens as Causes of Health Care Associated Infections in Adult Cancer Patients

Abstract Full-Text HTML XML

Download as PDF (Size:402KB) PP. 881-888

DOI: 10.4236/jct.2015.610096 3,373 Downloads 3,894 Views Citations

Author(s) Leave a comment

Hadir A. El-Mahallawy¹, Rasha M. Abdel Hamid¹, Safaa Shawky Hassan^1*, Samah Radwan¹, Magdy Saber²

Affiliation(s)

¹Clinical Pathology Department, National Cancer Institute, Cairo University, Giza, Egypt.
²Medical Oncology Department, National Cancer Institute, Cairo University, Giza, Egypt.

ABSTRACT

Background and Aim: Multi drug resistant Non fermenting gram negative bacilli (NFGNB) have emerged as a major cause of health-care associated infections especially in immunocompromised hosts. The aim of the study was to investigate the prevalence of NFGNB as a cause of health-care associated infections (HAI) in cancer patients and determine their resistance pattern. Patients and Methods: During the study period, 158 NFGNB isolates were collected. Microscan Walk Away 9 was used for identification and testing for the metallo-β-lactamases (MBLs) was done by Imipenem-EDTA combined disk synergy test (CDST-IPM). Results: NFGNB represented 29.0% of infections caused by gram negative organisms. Carbapenem resistance, the multi-drug resistant (MDR) phenotype, and MBL production were documented in 70%, 63%, and 59% of NFGNB isolates, respectively. MDR-NFGNB rates were significantly higher among hospitalized patients, medical department and those with longer duration of hospital stay (p = 0.034, 0.026, 0.019; respectively) than non MDR-NFGNB. Conclusion: A high level of carbapenem and multi-drug resistance were detected among the non-fermenter pathogens isolated from hospitalized cases and were more frequently encountered in high risk adult cancer patients requiring longer duration of hospitalization. The MDR-NFGNB are constituting important causes of health-care associated infections in cancer patients.

KEYWORDS

Multi Drug Resistant Organisms (MDRO), Non-Fermenting Gram Negative Bacilli (NF-GNB), Metallo-β-Lactamases (MBL), Surgical Site Infections (SSI)

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

El-Mahallawy, H. , Hamid, R. , Hassan, S. , Radwan, S. and Saber, M. (2015) The Increased Frequency of Carbapenem Resistant Non Fermenting Gram Negative Pathogens as Causes of Health Care Associated Infections in Adult Cancer Patients. Journal of Cancer Therapy, 6, 881-888. doi: 10.4236/jct.2015.610096.

References

[1]	Juyal, D., Prakash, R., Shanakarnarayan, S.A., Sharma, M., Negi, V. and Sharma, N. (2013) Prevalence of Non-Fermenting Gram Negative Bacilli and Their in Vitro Susceptibility Pattern in a Tertiary Care Hospital of Uttarakhand: A Study from Foothills of Himalayas. Saudi Journal for Health Science, 2, 108-112. http://dx.doi.org/10.4103/2278-0521.117915

[2]	Karjigi, S., Golia, S. and Reddy, M.K. (2013) Phenotypic Characterization and Antibiotic Susceptibility Pattern of Non-Fermentative Gram Negative Bacilli from Clinical Samples. International Journal of Basic and Applied Medical Sciences, 3, 248-255.

[3]	Rit, K., Nag, F., Raj, H.J. and Maity, P.K. (2013) Prevalence and Susceptibility Profiles of Non-Fermentative Gram Negative Bacilli Infection in a Tertiary Care Hospital of Eastern India. Indian Journal of Clinical Practice, 24, 451-455.

[4]	Hodiwala, A., Dhoke, R. and Urhekar, A.D. (2013) Incidence of Metallo-Beta-Lactamase Producing Pseudomonas, Acinetobacter & Enterobacterial Isolates in Hospitalised Patients. International Journal of Pharmacy and Biological Sciences, 3, 79-83.

[5]	Mohanty, S., Maurya, V., Gaind, R. and Deb, M. (2013) Phenotypic Characterization and Colistin Susceptibilities of Carbapenem-Resistant of Pseudomonas aeruginosa and Acinetobacter spp. Journal of Infection in Developing Countries, 7, 880-887. http://dx.doi.org/10.3855/jidc.2924

[6]	Omair, M., Usman, J., Kaleem, F., Hassan, A., Khalid, A. and Fahim, Q. (2012) Evaluation of Combined Disc Method for the Detection of Metallo-β-Lactamase Producing Gram Negative Bacilli. Malaysian Journal of Microbiology, 8, 21-25.

[7]	Pandya, N.P., Prajapati, S.B., Mehta, S.J., Kikani, K.M. and Joshi, P.J. (2011) Evaluation of Various Methods for Detection of Metallo-β-Lactamase (MBL) Production in Gram Negative Bacilli. International Journal of Biological and Medical Research, 2, 775-777.

[8]	CLSI (2010) Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. CLSI Document M100-S20. Clinical and Laboratory Standards Institute, Wayne.

[9]	Vaze, N.D., Emery, C.L., Hamilton, R.J., Brooks, A.D. and Joshi, S.G. (2013) Patient Demographics and Characteristics of Infection with Carbapenem-Resistant Acinetobacter baumannii in a Teaching Hospital from the United States. Advances in Infectious Diseases, 3, 10-16. http://dx.doi.org/10.4236/aid.2013.31002

[10]	Upgade, A., Prabhu, N., Gopi, V. and Soundararajan, N. (2012) Current Status of Antibiotic Resistant Non-Fermentative Gram Negative Bacilli among Nosocomial Infections. Advances in Applied Science Research, 3, 738-742.

[11]	Jayanthi, S. and Jeya, M. (2012) Clinical Distribution and Antibiotic Resistance Pattern of Non-Fermenting Gram Negative Bacilli. International Journal of Pharma and Bio Sciences, 3, 487-494.

[12]	Thipperudraswamy, T., Sudhindra, K.S., Nadigar, S. and Kumar, M. (2014) Prevalence of Non-Fermenting Gram Negative Bacilli from Clinical Isolates and Their Antibiogram Profile. Journal of Biomedical and Pharmaceutical Research, 3, 55-61.

[13]	Netsvyetayeva, I., Sikora, M., Golas, M., et al. (2011) Acinetobacter baumannii Multidrug-Resistant Strain Occurrence in Liver Recipients with Reference to Other High-Risk Groups. Transplantation Proceedings, 43, 3116-3120. http://dx.doi.org/10.1016/j.transproceed.2011.07.008

[14]	Peters, B.M., Jabra-Rizk, M.A., O’May, G.A., Costerton, J.W. and Shirtliff, M.E. (2012) Polymicrobial Interactions: Impact on Pathogenesis and Human Disease. Clinical Microbiology Reviews, 25, 193-213. http://dx.doi.org/10.1128/CMR.00013-11

[15]	Ahmad, A.S., Ormiston-Smith, N. and Sasieni, P.D. (2015) Trends in the Lifetime Risk of Developing Cancer in Great Britain: Comparison of Risk for Those Born from 1930 to 1960. British Journal of Cancer, 112, 943-947. http://dx.doi.org/10.1038/bjc.2014.606

[16]	Prata-Rocha, M.L., Moreira, M.R., Gontijo Filho, P.P. and Melo, G.B. (2013) Acinetobacter baumannii: Global Evolution of Carbapenem-Resistant and Genotyping Methods. Microbial Pathogens and Strategies for Combating Them: Science, Technology and Education, 1, 197-203.

[17]	Rahbar, M., Mehragan, H. and Akbari, N.H.A. (2010) Prevalence of Drug Resistance in Non-Fermenter Gram-Negative Bacilli. Iranian Journal of Pathology, 5, 90-96.

[18]	Zahid, M., Akbar, M., Sthanadar, A.A., Ali, P.A., et al. (2014) Isolation and Identification of Multi-Drug Resistant Strains of Non-Lactose Fermenting Bacteria from Clinical Refuses in Major Hospitals of Khyber Pakhtunkhwa, Pakistan. Open Journal of Medical Microbiology, 4, 124-131. http://dx.doi.org/10.4236/ojmm.2014.42014

[19]	Daef, E.A., Mohamed, I.S., Ahmed, A.S., Elsherbiny, N.M. and Sayed, I.M. (2012) Evaluation of Different Phenotypic Assays for the Detection of Metallo-β-Lactamase Production in Carbapenem Susceptible and Resistant Acinetobacter baumannii Isolates. Journal of American Science, 8, 292-299.